Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection

  1. Montes de Oca Arjona, M.
  2. Pérez Cano, R.
  3. Orozco, M.J.
  4. Martín Aspas, A.
  5. Guerrero, F.
  6. Fernández Gutiérrez del Álamo, C.
  7. Girón-González, J.A.
Journal:
Clinical Microbiology and Infection

ISSN: 1198-743X

Year of publication: 2005

Volume: 11

Issue: 1

Pages: 57-62

Type: Article

DOI: 10.1111/J.1469-0691.2004.01033.X GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus